 |
 |

Is Neuromyelitis Optica Eyeing a Distinct Path From Multiple Sclerosis?
Christopher C. Glisson, DO;
Steven L. Galetta, MD
Arch Ophthalmol. 2008;126(1):128-129.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
Devic1 originally defined neuromyelitis optica (NMO) in the late 19th century as an acute monophasic syndrome characterized by bilateral (or rapidly sequential) optic neuritis and severe myelitis; attacks were limited to the optic nerve and spinal cord and resulted in significant disability. Subsequently, variations in clinical presentation, frequency of relapses, and degree of severity have been reported.2-7 Since 1999, 2 versions of standardized clinical criteria for the diagnosis of NMO have been suggested,8-9 and further revisions are likely in the near future. Given the lack of precisely defined clinical and diagnostic features, controversy has emerged regarding the potential relationship of NMO with other inflammatory conditions of the central nervous system, most notably multiple sclerosis (MS). The need to clearly distinguish between these conditions at the time of diagnosis, however, may be critical, given the perceived deleterious effect of NMO on neurologic function . . . [Full Text of this Article] AUTHOR INFORMATION
RELATED ARTICLE
Clinical Course of Optic Neuritis in Patients With Relapsing Neuromyelitis Optica
Regina Maria Papais-Alvarenga, Sandro Carvalho Carellos, Marcos Papais Alvarenga, Clarice Holander, Roberly Pinto Bichara, and Luiz Claudio Santos Thuler
Arch Ophthalmol. 2008;126(1):12-16.
ABSTRACT
| FULL TEXT
|